Large-scale testing (Phase 3)WithdrawnNCT03619005
What this trial is testing
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
Who this might be right for
Hypoactive Sexual Desire Disorder (HSDD)
EndoCeutics Inc.